Mustang Bio Inc. (NASDAQ: MBIO)
$0.40
+0.0041 ( +1.03% ) 1.2M
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
Market Data
Open
$0.40
Previous close
$0.40
Volume
1.2M
Market cap
$13.06M
Day range
$0.39 - $0.41
52 week range
$0.13 - $5.66
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
def | Proxies and info statements | 2 | Jul 10, 2024 |
8-k | 8K-related | 14 | Jul 03, 2024 |
pre | Proxies and info statements | 2 | Jun 28, 2024 |
8-k | 8K-related | 13 | Jun 06, 2024 |
4 | Insider transactions | 1 | Jun 04, 2024 |
4 | Insider transactions | 1 | Jun 04, 2024 |
8-k | 8K-related | 13 | May 21, 2024 |
10-q | Quarterly Reports | 69 | May 15, 2024 |
8-k | 8K-related | 21 | May 02, 2024 |
8-k | 8K-related | 13 | Apr 29, 2024 |